Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Tempus AI

Tempus AI Stock: Time to Double Down or Cut and Run?

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential.

3 Hot New IPOs Defying the 2025 Market Slump

3 Hot New IPOs Defying the 2025 Market Slump

Tempus AI, ServiceTitan, and CoreWeave are 2025 IPO standouts, defying a down market. Here’s how they’re beating the S&P 500 so far this year.

Nancy Pelosi's 2025 Stock Buys Worth $1.95M are Deep in Red, Some as Much as 57%

Nancy Pelosi's 2025 Stock Buys Worth $1.95M are Deep in Red, Some as Much as 57%

Former House Speaker Nancy Pelosi purchased call option contracts of companies, including Alphabet, Amazon, Nvidia, Vistra Corp, and Tempus AI, in January.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

4 Healthcare Stocks With Massive Gains—and More to Come

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

Nancy Pelosi's Net Worth Has Dropped By £11.23M After Trump Took Office

Nancy Pelosi's investments in top tech giants have markedly declined after Trump's tariff plans introduced volatility in stock markets.

International Business Times UK

Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?

The popular investor poured $366.2 million in the company’s shares to carry out her latest purchase.

Tempus AI Is a Buy, If You Can Handle the Volatility

Tempus AI is well-positioned to capitalize on its extensive clinical data database. It can provide personalized treatment for hard-to-treat illness.

inkl

Read news from The Economist, FT, and more,
with one subscription

Nancy Pelosi's Tempus AI Stock Investment Jumps Over 300% in 40 Days

Nancy Pelosi's Tempus AI Stock Investment Jumps Over 300% in 40 Days

Pelosi's Tempus AI call options contracts tripled in value in 40 days as the healthcare firm continued its upward rally on AI-product launches and active collaborations to battle diseases like cancer.

International Business Times UK

Conflicting Signals: Tempus AI's Stock Market Rally

Conflicting Signals: Tempus AI's Stock Market Rally

Tempus AI's stock has soared on completed acquisitions and product launches, yet mixed analyst sentiment signals a need for careful investor review.

Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound

Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound

Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.

Pelosi Bets Big on AI: This Is What You Need to Know

Pelosi Bets Big on AI: This Is What You Need to Know

Congressional Whale Nancy Pelosi is in the spotlight, buying significant positions in tech stocks like NVDA and other AI plays.

Pelosi Sells 31K Apple and 10K Nvidia Shares, Eyes New AI and Utility Firm in a Major Portfolio Reshuffle

Pelosi Sells 31K Apple and 10K Nvidia Shares, Eyes New AI and Utility Firm in a Major Portfolio Reshuffle

Pelosi sold Apple and Nvidia shares while betting on Tempus AI and Vistra Corp. She also bought call options for both Amazon and Alphabet Class A stocks.

International Business Times UK

Tempus AI: A Potential Double-Bagger After Recent Pullback

Tempus AI: A Potential Double-Bagger After Recent Pullback

AI healthcare stock Tempus AI has seen its value fall off a cliff recently. However, Wall Street remains bullish, seeing significant upside in the shares.

1 AI Stock Cathie Wood Is Buying Instead of Tesla

1 AI Stock Cathie Wood Is Buying Instead of Tesla

Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.

Get all your
news in one place.

100's of premium titles.
One news app.

Should You Follow Cathie Wood Into This AI Diagnostics Stock?

This AI diagnostics stock is a holding in Wood's ARKK and ARKG ETFs.

1 2 3

People

202,212 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Amazon.com Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

397,431 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play